Viatris (VTRS) Competitors

Viatris (NASDAQ:VTRS) and argenx (NASDAQ:ARGX) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.

Is VTRS or ARGX more profitable?

argenx has a net margin of -2.11% compared to Viatris' net margin of -5.87%. Viatris' return on equity of 16.46% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Viatris	-5.87%	16.46%	7.09%
argenx	-2.11%	-1.45%	-1.29%

Do insiders & institutionals have more ownership in VTRS or ARGX?

79.9% of Viatris shares are owned by institutional investors. Comparatively, 60.3% of argenx shares are owned by institutional investors. 0.1% of Viatris shares are owned by insiders. Comparatively, 2.4% of argenx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the media refer more to VTRS or ARGX?

In the previous week, argenx had 7 more articles in the media than Viatris. MarketBeat recorded 19 mentions for argenx and 12 mentions for Viatris. argenx's average media sentiment score of 0.97 beat Viatris' score of -0.10 indicating that argenx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Viatris	2 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
argenx	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, VTRS or ARGX?

Viatris has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, argenx has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Does the MarketBeat Community believe in VTRS or ARGX?

argenx received 630 more outperform votes than Viatris when rated by MarketBeat users. Likewise, 67.32% of users gave argenx an outperform vote while only 34.85% of users gave Viatris an outperform vote.

Company	Underperform	Outperform
Viatris	Outperform Votes 23 34.85%	Underperform Votes 43 65.15%
argenx	Outperform Votes 653 67.32%	Underperform Votes 317 32.68%

Do analysts prefer VTRS or ARGX?

Viatris presently has a consensus target price of $10.50, indicating a potential upside of 12.42%. argenx has a consensus target price of $687.00, indicating a potential upside of 18.36%. Given argenx's stronger consensus rating and higher possible upside, analysts clearly believe argenx is more favorable than Viatris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viatris	2 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75
argenx	1 Sell rating(s)	2 Hold rating(s)	18 Buy rating(s)	1 Strong Buy rating(s)	2.86

Which has better valuation & earnings, VTRS or ARGX?

Viatris has higher revenue and earnings than argenx. Viatris is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viatris	$14.74B	0.76	$54.70M	-$0.53	-17.62
argenx	$2.19B	16.10	-$295.05M	$12.59	46.10

Summary

argenx beats Viatris on 12 of the 19 factors compared between the two stocks.